Daily Medication Pearl: Besifloxacin (Besivance)


Besifloxacin ophthalmic suspension (Besivance) is indicated for the treatment of bacterial conjunctivitis.

Medication Pearl of the Day: Besivance (besifloxacin)

Indication: Besifloxacin ophthalmic suspension (Besivance) 0.6% is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis.


  • Dosing: Instill 1 drop in the affected eye(s) 3 times a day, 4 to 12 hours apart for 7 days.
  • Dosage forms:Ophthalmic suspension besifloxacin 6 mg/mL.
  • Adverse events: The most common adverse reaction reported in 2% of patients treated with Besivance was conjunctival redness.
  • Mechanism of action: Besifloxacin is a fluoroquinolone antibacterial agent.
  • Manufacturer: Bausch & Lomb Incorporated.


Related Videos
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Image credit: rawpixel.com | stock.adobe.com
Medical team -- Image credit: Flamingo Images | stock.adobe.com
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.